Express Scripts Holding Profit Margin 2006-2018 | ESRX

Current and historical gross margin, operating margin and net profit margin for Express Scripts Holding (ESRX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Express Scripts Holding net profit margin as of September 30, 2018 is 4.83%.
Express Scripts Holding Annual Profit Margins
Express Scripts Holding Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Services $54.627B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.463B 23.39
PRA Health Sciences (PRAH) United States $6.620B 27.02
Charles River Laboratories (CRL) United States $6.310B 22.12
HealthEquity (HQY) United States $5.521B 115.57
Premier (PINC) United States $5.378B 18.33
INC Research Holdings (SYNH) United States $5.128B 20.70
Teladoc (TDOC) United States $4.102B 0.00
NovoCure (NVCR) Jersey $2.920B 0.00
AMN Healthcare Services Inc (AMN) United States $2.679B 18.38
Medpace Holdings (MEDP) United States $2.042B 25.26
BioTelemetry (BEAT) United States $2.004B 35.41
Healthways (TVTY) United States $1.482B 18.23
Intrexon (XON) United States $1.385B 0.00
IKang Healthcare (KANG) China $1.075B 53.38
CareDx (CDNA) United States $0.992B 0.00
Natera (NTRA) United States $0.986B 0.00
China Cord Blood (CO) China $0.800B 21.23
Surgery Partners (SGRY) United States $0.669B 0.00
Apollo Medical Holdings (AMEH) United States $0.600B 0.00
Establishment Labs Holdings (ESTA) $0.553B 0.00
Civitas Solutions (CIVI) United States $0.526B 10.37
OncoCyte (OCX) United States $0.074B 0.00
Interpace Diagnostics (IDXG) United States $0.042B 0.00
Cancer Genetics (CGIX) United States $0.017B 0.00
OpGen (OPGN) United States $0.008B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.004B 0.00